Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arianna Kee

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 12, 2019
Value-Based Contracting: Challenges and OpportunitiesArianna Kee, Vittorio Maio
The Oncologist|March 11, 2022
Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United StatesRonda Copher, Arianna Kee, Aaron Gerds
Drugs - Real World Outcomes|June 17, 2021
Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying TherapyLeorah Freeman, Arianna Kee, Marc Tian, et al.
Future Oncology (London, England)|February 1, 2021
Real-world treatment patterns, healthcare use and costs in triple-class exposed relapsed and refractory multiple myeloma patients in the USADeepu Madduri, May Hagiwara, Kejal Parikh, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 12, 2019
Value-Based Contracting: Challenges and OpportunitiesArianna Kee, Vittorio Maio
The Oncologist|March 11, 2022
Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United StatesRonda Copher, Arianna Kee, Aaron Gerds
Drugs - Real World Outcomes|June 17, 2021
Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying TherapyLeorah Freeman, Arianna Kee, Marc Tian, et al.
Future Oncology (London, England)|February 1, 2021
Real-world treatment patterns, healthcare use and costs in triple-class exposed relapsed and refractory multiple myeloma patients in the USADeepu Madduri, May Hagiwara, Kejal Parikh, et al.
Pageof 1